https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Belarus. en Sat, 07 Nov 2026 03:45:11 GMT https://papers.globalinfectiousdisease.com/research/articles/10-1038-s44259-026-00265-w-655bf7ff/ https://papers.globalinfectiousdisease.com/research/articles/10-1038-s44259-026-00265-w-655bf7ff/ Sat, 05 Sep 2026 00:00:00 GMT The authors state the results inform TB control in low- and high-burden settings and show drug-resistant TB as an interconnected global issue. Tuberculosis Antimicrobial resistance Genomic epidemiology Genomic study https://papers.globalinfectiousdisease.com/research/articles/10-1038-s41467-026-74335-y-3df8d3fe/ https://papers.globalinfectiousdisease.com/research/articles/10-1038-s41467-026-74335-y-3df8d3fe/ Wed, 10 Jun 2026 00:00:00 GMT The findings provide pharmacokinetic, bacterial-clearance, and toxicity context for short oral regimens used to treat rifampicin-resistant tuberculosis. The abstract states that the results strengthen the WHO recommendation that BPaLM is the preferred regimen for adolescents and adults with this condition. Tuberculosis Treatment Randomised controlled trial https://papers.globalinfectiousdisease.com/research/articles/10-1056-nejmoa2117166-dec33742/ https://papers.globalinfectiousdisease.com/research/articles/10-1056-nejmoa2117166-dec33742/ Thu, 22 Dec 2022 00:00:00 GMT The findings suggest a shorter, all-oral treatment option with improved safety may address clinical need for more effective and tolerable regimens in rifampin-resistant tuberculosis management. Tuberculosis Treatment Antimicrobial resistance Randomised controlled trial